Pricing Log in Create free account

Karyopharm Therapeutics Inc. (KPTI) vs Atrinsic Inc. (PTIX)

Karyopharm Therapeutics Inc. and Atrinsic Inc. are both Biotechnology companies. Karyopharm Therapeutics Inc. and Atrinsic Inc. are of similar size ($1.4M and $1.3M). Karyopharm Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.2×. Atrinsic Inc. has the higher net margin (0.00% vs −153.3%) and the lower return on invested capital (−229.9% vs 0.00%). Across the 13 metrics below, Atrinsic Inc. leads on 7 and Karyopharm Therapeutics Inc. on 6.

Valuation

Metric KPTI PTIX Biotechnology median
P/E n/m 0.24 10.60
P/S 0.01 n/m 9.40
P/B n/m 0.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.27 n/m 9.02
Earnings yield (25,680.00%) 412.96% (32.88%)
Free cash flow yield (4,526.16%) (220.47%) (23.13%)

Profitability

Metric KPTI PTIX Biotechnology median
Gross margin 95.89% 0.00% 68.51%
Operating margin (56.17%) 0.00% 0.00%
Net margin (153.28%) 0.00% 0.00%
Free cash flow margin (44.57%) 0.00% 0.00%
Return on equity 78.98% (338.24%) (51.96%)
Return on assets (207.90%) 378.63% (46.06%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric KPTI PTIX Biotechnology median
Revenue growth (TTM) 6.81% — 6.76%
EPS growth (last fiscal year) (28.07%) 188.24% 29.88%
Revenue growth, 5-year CAGR 6.21% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPTI PTIX Biotechnology median
Debt to equity (0.76) 0.00 0.00
Current ratio 0.79 0.66 4.97
Net debt to EBITDA (2.03) 0.52 1.01

Dividend

Metric KPTI PTIX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KPTI PTIX Biotechnology median
Market cap 1.36m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack